Evidence map›Paper›PMID 42297915›Full record

ArticleLeukemia2026

Response kinetics as a dynamic prognostic marker in patients with multiple myeloma.

Hee Jeong Cho, Myung-Won Lee, Jae Hoon Lee, Hyeon-Seok Eom, Jongheon Jung, Ho-Young Yhim, Dok Hyun Yoon, Hyungwoo Cho, Sung-Soo Yoon, Ja Min Byun and 12 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Hee Jeong ChoDepartment of Hematology/Oncology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, South Korea.ORCID http://orcid.org/0000-0001-8300-8179
Myung-Won LeeDivision of Hematology/Oncology, Department of Internal Medicine, Chungnam National University, Sejong, South Korea.
Jae Hoon LeeDivision of Hematology, Gachon University Gil Medical Center, Incheon, South Korea.
Hyeon-Seok EomCenter for Hematologic Malignancy, National Cancer Center, Goyang, South Korea.
Jongheon JungCenter for Hematologic Malignancy, National Cancer Center, Goyang, South Korea.
Ho-Young YhimDepartment of Internal Medicine, Jeonbuk National University Medical School, Jeonju, South Korea.ORCID http://orcid.org/0000-0002-1252-5336
Dok Hyun YoonAsan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Hyungwoo ChoAsan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Sung-Soo YoonDepartment of Internal Medicine, Kyung Hee University College of Medicine, Seoul, South Korea.ORCID http://orcid.org/0000-0003-2591-7459
Ja Min ByunDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea.
Young Rok DoDepartment of Hemato-Oncology, Keimyung University Dongsan Medical Center, Daegu, South Korea.
Hyo Jung KimDivision of Hematology-Oncology, Department of Internal medicine, Hallym University Sacred Heart Hospital, Anyang, South Korea.
Ji Hyun LeeDivision of Hematology-Oncology, Department of Internal medicine, Dong-A University College of Medicine, Busan, South Korea.ORCID http://orcid.org/0000-0003-2341-4911
Sung-Nam LimDepartment of Hematology-Oncology, Inje University Haeundae Paik Hospital, Busan, South Korea.
Hye Jin KangDivision of Hematology/Oncology, Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Science, Seoul, South Korea.
Ho Sup LeeDepartment of Internal Medicine, Kosin University Gospel Hospital, Busan, South Korea.
Yundeok KimWonju Severance Christian Hospital, Wonju, South Korea.
Hee Jeong LeeDepartment of Internal Medicine, Hemato-oncology, Chosun University Hospital, Gwangju, South Korea.
Sang Min LeeInje University Busan Paik Hospital, Busan, South Korea.ORCID http://orcid.org/0000-0002-9714-9615
Kihyun Kim *Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. kihyunkimk@gmail.com.ORCID http://orcid.org/0000-0002-5878-8895
Joon Ho Moon *Department of Hematology/Oncology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, South Korea. jhmoon@knu.ac.kr.ORCID http://orcid.org/0000-0003-3756-796X
Korean Multiple Myeloma Working Party (KMM2303)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42297915
PMCPMC13323071

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.